Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 114

1.

Macrophages induce malignant traits in mammary epithelium via IKKε/TBK1 kinases and the serine biosynthesis pathway.

Wilcz-Villega E, Carter E, Ironside A, Xu R, Mataloni I, Holdsworth J, Jones W, Moreno Béjar R, Uhlik L, Bentham RB, Godinho SA, Dalli J, Grose R, Szabadkai G, Jones L, Hodivala-Dilke K, Bianchi K.

EMBO Mol Med. 2020 Feb 7;12(2):e10491. doi: 10.15252/emmm.201910491. Epub 2020 Jan 13.

2.

Sexual and Reproductive Health Outcomes of Violence Against Women and Girls in Lower-Income Countries: A Review of Reviews.

Grose RG, Chen JS, Roof KA, Rachel S, Yount KM.

J Sex Res. 2020 Jan 4:1-20. doi: 10.1080/00224499.2019.1707466. [Epub ahead of print]

PMID:
31902238
3.

Lineage of measurable residual disease in patients with chronic myeloid leukemia in treatment-free remission.

Pagani IS, Dang P, Saunders VA, Grose R, Shanmuganathan N, Kok CH, Carne L, Rwodzi Z, Watts S, McLean J, Braley J, Altamura H, Yeung DT, Branford S, Yong ASM, White DL, Hughes TP, Ross DM.

Leukemia. 2019 Nov 25. doi: 10.1038/s41375-019-0647-x. [Epub ahead of print]

PMID:
31768016
4.

Pancreatic Cancer Organotypic Models.

Coetzee A, Grose R, Kocher H.

Curr Top Microbiol Immunol. 2019 Feb 22. doi: 10.1007/82_2019_155. [Epub ahead of print]

PMID:
30790075
5.

Community Influences on Female Genital Mutilation/Cutting in Kenya: Norms, Opportunities, and Ethnic Diversity.

Grose RG, Hayford SR, Cheong YF, Garver S, Kandala NB, Yount KM.

J Health Soc Behav. 2019 Mar;60(1):84-100. doi: 10.1177/0022146518821870. Epub 2019 Jan 7.

PMID:
30614273
6.

Emerging Roles of Fibroblast Growth Factor 10 in Cancer.

Clayton NS, Grose RP.

Front Genet. 2018 Oct 24;9:499. doi: 10.3389/fgene.2018.00499. eCollection 2018.

7.

mTORC1 plays an important role in osteoblastic regulation of B-lymphopoiesis.

Martin SK, Fitter S, El Khawanky N, Grose RH, Walkley CR, Purton LE, Ruegg MA, Hall MN, Gronthos S, Zannettino ACW.

Sci Rep. 2018 Sep 28;8(1):14501. doi: 10.1038/s41598-018-32858-5.

8.

Cell banking for regulatory T cell-based therapy: strategies to overcome the impact of cryopreservation on the Treg viability and phenotype.

Gołąb K, Grose R, Placencia V, Wickrema A, Solomina J, Tibudan M, Konsur E, Ciepły K, Marek-Trzonkowska N, Trzonkowski P, Millis JM, Fung J, Witkowski P.

Oncotarget. 2018 Jan 3;9(11):9728-9740. doi: 10.18632/oncotarget.23887. eCollection 2018 Feb 9.

9.

PHLDA1 Mediates Drug Resistance in Receptor Tyrosine Kinase-Driven Cancer.

Fearon AE, Carter EP, Clayton NS, Wilkes EH, Baker AM, Kapitonova E, Bakhouche BA, Tanner Y, Wang J, Gadaleta E, Chelala C, Moore KM, Marshall JF, Chupin J, Schmid P, Jones JL, Lockley M, Cutillas PR, Grose RP.

Cell Rep. 2018 Feb 27;22(9):2469-2481. doi: 10.1016/j.celrep.2018.02.028.

10.

A novel fluorescent probe reveals starvation controls the commitment of amyloid precursor protein to the lysosome.

Hein LK, Apaja PM, Hattersley K, Grose RH, Xie J, Proud CG, Sargeant TJ.

Biochim Biophys Acta Mol Cell Res. 2017 Oct;1864(10):1554-1565. doi: 10.1016/j.bbamcr.2017.06.011. Epub 2017 Jun 19.

11.

Fibroblast growth factor-mediated crosstalk in cancer etiology and treatment.

Clayton NS, Wilson AS, Laurent EP, Grose RP, Carter EP.

Dev Dyn. 2017 Jul;246(7):493-501. doi: 10.1002/dvdy.24514. Epub 2017 May 18. Review.

12.

A 3D in vitro model of the human breast duct: a method to unravel myoepithelial-luminal interactions in the progression of breast cancer.

Carter EP, Gopsill JA, Gomm JJ, Jones JL, Grose RP.

Breast Cancer Res. 2017 Apr 21;19(1):50. doi: 10.1186/s13058-017-0843-4.

13.

3D Organotypic Culture Model to Study Components of ERK Signaling.

Chioni AM, Bajwa RT, Grose R.

Methods Mol Biol. 2017;1487:255-267.

PMID:
27924573
14.

Utilization of leukapheresis and CD4 positive selection in Treg isolation and the ex-vivo expansion for a clinical application in transplantation and autoimmune disorders.

Gołąb K, Grose R, Trzonkowski P, Wickrema A, Tibudan M, Marek-Trzonkowska N, Matosz S, Solomina J, Ostrega D, Michael Millis J, Witkowski P.

Oncotarget. 2016 Nov 29;7(48):79474-79484. doi: 10.18632/oncotarget.13101.

15.

Reduced Expression of Histone Methyltransferases KMT2C and KMT2D Correlates with Improved Outcome in Pancreatic Ductal Adenocarcinoma.

Dawkins JB, Wang J, Maniati E, Heward JA, Koniali L, Kocher HM, Martin SA, Chelala C, Balkwill FR, Fitzgibbon J, Grose RP.

Cancer Res. 2016 Aug 15;76(16):4861-71. doi: 10.1158/0008-5472.CAN-16-0481. Epub 2016 Jun 8.

16.

Anti-stromal treatment together with chemotherapy targets multiple signalling pathways in pancreatic adenocarcinoma.

Carapuça EF, Gemenetzidis E, Feig C, Bapiro TE, Williams MD, Wilson AS, Delvecchio FR, Arumugam P, Grose RP, Lemoine NR, Richards FM, Kocher HM.

J Pathol. 2016 Jul;239(3):286-96. doi: 10.1002/path.4727. Epub 2016 May 25.

17.

TGF-α and IL-6 plasma levels selectively identify CML patients who fail to achieve an early molecular response or progress in the first year of therapy.

Nievergall E, Reynolds J, Kok CH, Watkins DB, Biondo M, Busfield SJ, Vairo G, Fuller K, Erber WN, Sadras T, Grose R, Yeung DT, Lopez AF, Hiwase DK, Hughes TP, White DL.

Leukemia. 2016 Jun;30(6):1263-72. doi: 10.1038/leu.2016.34. Epub 2016 Feb 22.

PMID:
26898188
18.

Dysregulated FGF signalling in neoplastic disorders.

Tanner Y, Grose RP.

Semin Cell Dev Biol. 2016 May;53:126-35. doi: 10.1016/j.semcdb.2015.10.012. Epub 2015 Oct 19. Review.

PMID:
26463732
19.

Co-targeting AR and HSP90 suppresses prostate cancer cell growth and prevents resistance mechanisms.

Centenera MM, Carter SL, Gillis JL, Marrocco-Tallarigo DL, Grose RH, Tilley WD, Butler LM.

Endocr Relat Cancer. 2015 Oct;22(5):805-18. doi: 10.1530/ERC-14-0541. Epub 2015 Jul 17.

PMID:
26187127
20.

Preservation of beta cell function after pancreatic islet autotransplantation: University of Chicago experience.

Savari O, Golab K, Wang LJ, Schenck L, Grose R, Tibudan M, Ramachandran S, Chon WJ, Posner MC, Millis JM, Matthews JB, Gelrud A, Witkowski P.

Am Surg. 2015 Apr;81(4):421-7.

PMID:
25831191
21.

Adaptive Upregulation of EGFR Limits Attenuation of Tumor Growth by Neutralizing IL6 Antibodies, with Implications for Combined Therapy in Ovarian Cancer.

Milagre CS, Gopinathan G, Everitt G, Thompson RG, Kulbe H, Zhong H, Hollingsworth RE, Grose R, Bowtell DD, Hochhauser D, Balkwill FR.

Cancer Res. 2015 Apr 1;75(7):1255-64. doi: 10.1158/0008-5472.CAN-14-1801. Epub 2015 Feb 10.

22.

Careless talk costs lives: fibroblast growth factor receptor signalling and the consequences of pathway malfunction.

Carter EP, Fearon AE, Grose RP.

Trends Cell Biol. 2015 Apr;25(4):221-33. doi: 10.1016/j.tcb.2014.11.003. Epub 2014 Nov 29. Review.

PMID:
25467007
23.

Donor height in combination with islet donor score improves pancreas donor selection for pancreatic islet isolation and transplantation.

Wang LJ, Cochet O, Wang XJ, Krzystyniak A, Misawa R, Golab K, Tibudan M, Grose R, Savari O, Millis JM, Witkowski P.

Transplant Proc. 2014 Jul-Aug;46(6):1972-4. doi: 10.1016/j.transproceed.2014.05.076.

24.

Improved coating of pancreatic islets with regulatory T cells to create local immunosuppression by using the biotin-polyethylene glycol-succinimidyl valeric acid ester molecule.

Gołąb K, Kizilel S, Bal T, Hara M, Zielinski M, Grose R, Savari O, Wang XJ, Wang LJ, Tibudan M, Krzystyniak A, Marek-Trzonkowska N, Millis JM, Trzonkowski P, Witkowski P.

Transplant Proc. 2014 Jul-Aug;46(6):1967-71. doi: 10.1016/j.transproceed.2014.05.075.

25.

The explanatory role of relationship power and control in domestic violence against women in Nicaragua: a feminist psychology analysis.

Grose RG, Grabe S.

Violence Against Women. 2014 Aug;20(8):972-93. doi: 10.1177/1077801214546231. Epub 2014 Aug 14.

PMID:
25125492
26.

Pancreatic cancer organotypics: High throughput, preclinical models for pharmacological agent evaluation.

Coleman SJ, Watt J, Arumugam P, Solaini L, Carapuca E, Ghallab M, Grose RP, Kocher HM.

World J Gastroenterol. 2014 Jul 14;20(26):8471-81. doi: 10.3748/wjg.v20.i26.8471. Review.

27.

The ins and outs of fibroblast growth factor receptor signalling.

Coleman SJ, Bruce C, Chioni AM, Kocher HM, Grose RP.

Clin Sci (Lond). 2014 Aug;127(4):217-31. doi: 10.1042/CS20140100. Review.

PMID:
24780002
28.

Sociocultural attitudes surrounding menstruation and alternative menstrual products: the explanatory role of self-objectification.

Grose RG, Grabe S.

Health Care Women Int. 2014;35(6):677-94. doi: 10.1080/07399332.2014.888721. Epub 2014 Mar 26.

PMID:
24527840
29.

Nuclear translocation of FGFR1 and FGF2 in pancreatic stellate cells facilitates pancreatic cancer cell invasion.

Coleman SJ, Chioni AM, Ghallab M, Anderson RK, Lemoine NR, Kocher HM, Grose RP.

EMBO Mol Med. 2014 Apr;6(4):467-81. doi: 10.1002/emmm.201302698. Epub 2014 Feb 6.

30.

Grb-ing receptor activation by the tail.

Fearon AE, Grose RP.

Nat Struct Mol Biol. 2014 Feb;21(2):113-4. doi: 10.1038/nsmb.2767. No abstract available.

PMID:
24500424
31.

Identification of ZDHHC14 as a novel human tumour suppressor gene.

Yeste-Velasco M, Mao X, Grose R, Kudahetti SC, Lin D, Marzec J, Vasiljević N, Chaplin T, Xue L, Xu M, Foster JM, Karnam SS, James SY, Chioni AM, Gould D, Lorincz AT, Oliver RT, Chelala C, Thomas GM, Shipley JM, Mather SJ, Berney DM, Young BD, Lu YJ.

J Pathol. 2014 Apr;232(5):566-77. doi: 10.1002/path.4327. Epub 2014 Feb 8. Erratum in: J Pathol. 2014 Sep;234(1):134.

PMID:
24407904
32.

Fibroblast growth factor family as a potential target in the treatment of hepatocellular carcinoma.

Coleman SJ, Grose RP, Kocher HM.

J Hepatocell Carcinoma. 2014 May 29;1:43-54. doi: 10.2147/JHC.S48958. eCollection 2014. Review.

33.

Functional analysis of a breast cancer-associated FGFR2 single nucleotide polymorphism using zinc finger mediated genome editing.

Robbez-Masson LJ, Bödör C, Jones JL, Hurst HC, Fitzgibbon J, Hart IR, Grose RP.

PLoS One. 2013 Nov 12;8(11):e78839. doi: 10.1371/journal.pone.0078839. eCollection 2013.

34.

FGFR signalling in women's cancers.

Fearon AE, Gould CR, Grose RP.

Int J Biochem Cell Biol. 2013 Dec;45(12):2832-42. doi: 10.1016/j.biocel.2013.09.017. Epub 2013 Oct 19. Review.

PMID:
24148254
35.

Accumulation of effector memory CD8+ T cells in nasal polyps.

Pant H, Hughes A, Miljkovic D, Schembri M, Wormald P, Macardle P, Grose R, Zola H, Krumbiegel D.

Am J Rhinol Allergy. 2013 Sep-Oct;27(5):e117-26. doi: 10.2500/ajra.2013.27.3958.

PMID:
24119592
36.

Sexual education, gender ideology, and youth sexual empowerment.

Grose RG, Grabe S, Kohfeldt D.

J Sex Res. 2014;51(7):742-53. doi: 10.1080/00224499.2013.809511. Epub 2013 Sep 11.

PMID:
24024546
37.

Regulation of bone morphogenetic protein signalling and cranial osteogenesis by Gpc1 and Gpc3.

Dwivedi PP, Grose RH, Filmus J, Hii CS, Xian CJ, Anderson PJ, Powell BC.

Bone. 2013 Aug;55(2):367-76. doi: 10.1016/j.bone.2013.04.013. Epub 2013 Apr 25.

PMID:
23624389
38.

FGF signalling through Fgfr2 isoform IIIb regulates adrenal cortex development.

Guasti L, Candy Sze WC, McKay T, Grose R, King PJ.

Mol Cell Endocrinol. 2013 May 22;371(1-2):182-8. doi: 10.1016/j.mce.2013.01.014. Epub 2013 Jan 29.

39.

Cytoskeletal protein Flightless (Flii) is elevated in chronic and acute human wounds and wound fluid: neutralizing its activity in chronic but not acute wound fluid improves cellular proliferation.

Ruzehaji N, Grose R, Krumbiegel D, Zola H, Dasari P, Wallace H, Stacey M, Fitridge R, Cowin AJ.

Eur J Dermatol. 2012 Nov-Dec;22(6):740-50. doi: 10.1684/ejd.2012.1878.

PMID:
23178274
40.

Characterization of a distinct population of circulating human non-adherent endothelial forming cells and their recruitment via intercellular adhesion molecule-3.

Appleby SL, Cockshell MP, Pippal JB, Thompson EJ, Barrett JM, Tooley K, Sen S, Sun WY, Grose R, Nicholson I, Levina V, Cooke I, Talbo G, Lopez AF, Bonder CS.

PLoS One. 2012;7(11):e46996. doi: 10.1371/journal.pone.0046996. Epub 2012 Nov 7.

41.

FGF receptors 1 and 2 are key regulators of keratinocyte migration in vitro and in wounded skin.

Meyer M, Müller AK, Yang J, Moik D, Ponzio G, Ornitz DM, Grose R, Werner S.

J Cell Sci. 2012 Dec 1;125(Pt 23):5690-701. doi: 10.1242/jcs.108167. Epub 2012 Sep 19.

42.

Comparison of blood and synovial fluid th17 and novel peptidase inhibitor 16 Treg cell subsets in juvenile idiopathic arthritis.

Grose RH, Millard DJ, Mavrangelos C, Barry SC, Zola H, Nicholson IC, Cham WT, Boros CA, Krumbiegel D.

J Rheumatol. 2012 Oct;39(10):2021-31. doi: 10.3899/jrheum.111421. Epub 2012 Aug 15.

PMID:
22896021
43.

Fibroblast growth factor 22 is not essential for skin development and repair but plays a role in tumorigenesis.

Jarosz M, Robbez-Masson L, Chioni AM, Cross B, Rosewell I, Grose R.

PLoS One. 2012;7(6):e39436. doi: 10.1371/journal.pone.0039436. Epub 2012 Jun 21.

44.

FGFR1 cleavage and nuclear translocation regulates breast cancer cell behavior.

Chioni AM, Grose R.

J Cell Biol. 2012 Jun 11;197(6):801-17. doi: 10.1083/jcb.201108077. Epub 2012 Jun 4.

45.

PI16 is expressed by a subset of human memory Treg with enhanced migration to CCL17 and CCL20.

Nicholson IC, Mavrangelos C, Bird DR, Bresatz-Atkins S, Eastaff-Leung NG, Grose RH, Gundsambuu B, Hill D, Millard DJ, Sadlon TJ, To S, Zola H, Barry SC, Krumbiegel D.

Cell Immunol. 2012 Jan-Feb;275(1-2):12-8. doi: 10.1016/j.cellimm.2012.04.002. Epub 2012 Apr 6.

PMID:
22533972
46.

The autophagy-associated factors DRAM1 and p62 regulate cell migration and invasion in glioblastoma stem cells.

Galavotti S, Bartesaghi S, Faccenda D, Shaked-Rabi M, Sanzone S, McEvoy A, Dinsdale D, Condorelli F, Brandner S, Campanella M, Grose R, Jones C, Salomoni P.

Oncogene. 2013 Feb 7;32(6):699-712. doi: 10.1038/onc.2012.111. Epub 2012 Apr 23.

PMID:
22525272
47.

Non-junctional human desmoglein 3 acts as an upstream regulator of Src in E-cadherin adhesion, a pathway possibly involved in the pathogenesis of pemphigus vulgaris.

Tsang SM, Brown L, Lin K, Liu L, Piper K, O'Toole EA, Grose R, Hart IR, Garrod DR, Fortune F, Wan H.

J Pathol. 2012 May;227(1):81-93. doi: 10.1002/path.3982. Epub 2012 Feb 17.

PMID:
22294297
48.

Desmoglein 3, via an interaction with E-cadherin, is associated with activation of Src.

Tsang SM, Liu L, Teh MT, Wheeler A, Grose R, Hart IR, Garrod DR, Fortune F, Wan H.

PLoS One. 2010 Dec 3;5(12):e14211. doi: 10.1371/journal.pone.0014211.

49.

Fibroblast growth factor receptors 1 and 2 in keratinocytes control the epidermal barrier and cutaneous homeostasis.

Yang J, Meyer M, Müller AK, Böhm F, Grose R, Dauwalder T, Verrey F, Kopf M, Partanen J, Bloch W, Ornitz DM, Werner S.

J Cell Biol. 2010 Mar 22;188(6):935-52. doi: 10.1083/jcb.200910126.

50.

Fibroblast growth factor signalling: from development to cancer.

Turner N, Grose R.

Nat Rev Cancer. 2010 Feb;10(2):116-29. doi: 10.1038/nrc2780. Review.

PMID:
20094046

Supplemental Content

Support Center